864 related articles for article (PubMed ID: 14753747)
1. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
2. Immune response: the key to bone resorption in periodontal disease.
Taubman MA; Valverde P; Han X; Kawai T
J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.
Valverde P; Kawai T; Taubman MA
J Dent Res; 2005 Jun; 84(6):488-99. PubMed ID: 15914584
[TBL] [Abstract][Full Text] [Related]
4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
5. Bacterial-responsive B lymphocytes induce periodontal bone resorption.
Han X; Kawai T; Eastcott JW; Taubman MA
J Immunol; 2006 Jan; 176(1):625-31. PubMed ID: 16365458
[TBL] [Abstract][Full Text] [Related]
6. Immune Response: The Key to Bone Resorption in Periodontal Disease.
Taubman MA; Valverde P; Han X; Kawai T
J Periodontol; 2005 Nov; 76 Suppl 11S():2033-2041. PubMed ID: 29539039
[TBL] [Abstract][Full Text] [Related]
7. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.
Belibasakis GN; Johansson A; Wang Y; Chen C; Kalfas S; Lerner UH
Infect Immun; 2005 Jan; 73(1):342-51. PubMed ID: 15618171
[TBL] [Abstract][Full Text] [Related]
8. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.
Teng YT; Nguyen H; Gao X; Kong YY; Gorczynski RM; Singh B; Ellen RP; Penninger JM
J Clin Invest; 2000 Sep; 106(6):R59-67. PubMed ID: 10995794
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
[TBL] [Abstract][Full Text] [Related]
10. Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars.
Low E; Zoellner H; Kharbanda OP; Darendeliler MA
Am J Orthod Dentofacial Orthop; 2005 Oct; 128(4):497-503. PubMed ID: 16214633
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
[TBL] [Abstract][Full Text] [Related]
13. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.
Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I
Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325
[TBL] [Abstract][Full Text] [Related]
14. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
15. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
16. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
[TBL] [Abstract][Full Text] [Related]
17. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
Kawai T; Matsuyama T; Hosokawa Y; Makihira S; Seki M; Karimbux NY; Goncalves RB; Valverde P; Dibart S; Li YP; Miranda LA; Ernst CW; Izumi Y; Taubman MA
Am J Pathol; 2006 Sep; 169(3):987-98. PubMed ID: 16936272
[TBL] [Abstract][Full Text] [Related]
18. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease.
Kawai T; Eisen-Lev R; Seki M; Eastcott JW; Wilson ME; Taubman MA
J Immunol; 2000 Feb; 164(4):2102-9. PubMed ID: 10657664
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma agonist rosiglitazone prevents inflammatory periodontal bone loss by inhibiting osteoclastogenesis.
Hassumi MY; Silva-Filho VJ; Campos-Júnior JC; Vieira SM; Cunha FQ; Alves PM; Alves JB; Kawai T; Gonçalves RB; Napimoga MH
Int Immunopharmacol; 2009 Sep; 9(10):1150-8. PubMed ID: 19508902
[TBL] [Abstract][Full Text] [Related]
20. Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.
Wittrant Y; Theoleyre S; Couillaud S; Dunstan C; Heymann D; Rédini F
Exp Cell Res; 2004 Feb; 293(2):292-301. PubMed ID: 14729467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
